Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

Custom foam pillow OEM in Vietnam

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.High-performance insole OEM factory Taiwan

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Indonesia neck support pillow OEM

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Soft-touch pillow OEM manufacturing factory in Taiwan

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.China ergonomic pillow OEM supplier

Research conducted at KAUST aims to improve how stem cells move in the body so that they can reach where they are needed following transplantation. Credit: © 2021 KAUST; Anastasia Serin Molecules move within elongated protrusions to help stabilize migrating cells inside the bloodstream. An innovative experiment design shows, in real time and at the scale of a single molecule, how stem cells slow their rolling inside the circulatory system by growing long tethers that attach to the inner surfaces of blood vessels. The strategy could help researchers to improve stem cell transplantations and to find new treatments for metastasizing cancers. Many cells in the human body travel through blood vessels from one organ to another to carry out specific functions. For example, immune cells migrate to inflamed tissue, and cancer cells spread to new organs. Stem cells also travel to new locations to develop into different tissues. “This stem cell ‘homing,’ where cells migrate to their new place of residence, is also essential for successful bone marrow transplantation for treating various diseases,” explains Satoshi Habuchi, who led the study. Homing is a multistep process in which cells slowly roll over the inner lining of blood vessels, then adhere to the lining once they reach the site they are destined for, and finally transmigrate across the vessel wall into the tissue. Scientists already knew that homing cells produce tethers containing ligands that can sense and bind to adhesion molecules on the blood vessel lining. Until now, however, scientists had not been able to directly visualize this rolling to understand exactly what happens at the molecular level. Stem cell “homing” is a process whereby stem cells migrate through the circulatory system to arrive at the place where they are required in the human body. Credit: © 2021 KAUST; Anastasia Serin Satoshi, Merzaban, and their teams were able to mimic cell rolling by using a microfluidic system. “The tethering and rolling step of homing had previously been described as a simple binding between selectins on the endothelium and their ligands on stem cells,” says Ph.D. student Bader Al Alwan. “Our findings demonstrated that the initial step of homing is far more dynamic and complicated.” Part of the team’s research is focused on understanding why cancer cancer cells outperform normal cells in their ability to migrate around the human body. Credit: © 2021 KAUST; Anastasia Serin The team found that individual microvilli on the surface of the homing cells elongate to form individual tethers. Ligands in the microvilli rapidly extend throughout the tethers so they can “sniff out” selectin in the blood-vessel lining. Once located, the ligands bind to the selectins, attaching the tether to the vessel lining. This helps the cell resist the full strength of the blood flow. As the blood flow exerts pressure on the top of the cell, it rolls forward, stretching the tether until it reaches a critical point when it breaks and flips forward to come in front of the cell. Now called a sling, it is used to slow down the cell so that it can look for the molecules that signal where its new home is. “When we started, we did not expect that cell morphology played such a critical role in stabilizing cell rolling,” says Al Alwan. “We were also surprised by the extent to which the morphology changes, with some tethers merging into multiple ones and others stretching to more than ten times the length of the cell.” The team, led by Satoshi (right), want to create a more precise map of the proteins that are present at each step of the homing and migration process. Credit: © 2021 KAUST; Anastasia Serin “Our research is focused on understanding how various cells move in the body using adhesion systems. For example, one goal is to improve stem cell movement in the body so they can get where they are needed following transplantation or in other disease settings. We are also focused on understanding how and why cancer cells outperform normal cells in their ability to migrate so that we can develop methods to inhibit their metastasis. Using the sophisticated assays developed by Satoshi and his team, we also want to create a more precise map of the proteins that are present at each step of the homing and migration process to identify when and where they are important during migration,” says bioscientist Jasmeen Merzaban, the co-principal investigator of the study. Reference: “Single-molecule imaging and microfluidic platform reveal molecular mechanisms of leukemic cell rolling” by Bader Al Alwan, Karmen AbuZineh, Shuho Nozue, Aigerim Rakhmatulina, Mansour Aldehaiman, Asma S. Al-Amoodi, Maged F. Serag, Fajr A. Aleisa, Jasmeen S. Merzaban and Satoshi Habuchi, 14 July 2021, Communications Biology. DOI: 10.1038/s42003-021-02398-2

The Pol-theta enzyme (blue) joins two parts of a broken DNA strand (yellow). This process is mutagenic and can give rise to cancer. Credit: Scripps Research A new structural blueprint paves the way for improved targeting of cancer cells, particularly those with BRCA1 and BRCA2 mutations. DNA repair proteins function as the body’s molecular editors, continuously identifying and correcting damage to our genetic code. A longstanding challenge in cancer research has been understanding how cancer cells exploit one such protein—polymerase theta (Pol-theta)—to support their survival. Now, scientists at Scripps Research have captured the first high-resolution images of Pol-theta in action, shedding light on its role in cancer development. Published in Nature Structural & Molecular Biology on February 28, 2025, the study reveals that Pol-theta undergoes a significant structural transformation when binding to broken DNA strands. By mapping Pol-theta’s active, DNA-bound state, the research provides a foundation for designing more precise and effective cancer therapies. “We now have a much clearer picture of how Pol-theta works, which will enable us to block its activity more precisely,” says senior author Gabriel Lander, a professor at Scripps Research. Pol-theta: A Key Player in Cancer Cell Survival Technically, Pol-theta is an enzyme—a type of protein that speeds up chemical reactions, including those related to cell repair. DNA damage is a constant problem for cells, occurring millions of times per day collectively throughout our bodies. Cells normally use highly accurate mechanisms to fix these breaks, but some cancers—particularly those arising from BRCA1 or BRCA2 mutations, such as certain breast and ovarian cancers—lack this function. Instead, they depend on a more error-prone method, controlled by Pol-theta. “Pol-theta is an important target, and many pharmaceutical companies see it as a promising way to treat cancers that have defective DNA repair pathways,” adds first author Christopher Zerio, a former postdoctoral fellow in Lander’s lab. Although previous studies have mapped parts of Pol-theta’s structure, the enzyme’s interactions with DNA weren’t well understood. “What’s been missing is how Pol-theta actually engages DNA, which is essential for drug development,” says Zerio. Capturing Pol-theta in Action Prior research has shown that Pol-theta exists in two forms: a tetramer (four copies of the enzyme) and a dimer (two copies). But why or how Pol-theta changed between these forms was unknown. Before this study, Pol-theta’s structure had only been captured in an inactive state, leaving a major knowledge gap regarding how the enzyme interacts with DNA. It was like trying to determine how a bee accesses nectar when all you’ve ever seen is a closed flower. “You know the interaction must happen, but without seeing it, the mechanism remains a mystery,” explains Lander. Using cryo-electron microscopy and biochemical experiments, the team made a surprising discovery while capturing Pol-theta in the act of repairing DNA: Whenever Pol-theta bound to broken strands, it consistently switched from the tetrameric to a never-before-seen dimeric configuration. Once in its active state, Pol-theta repairs DNA using a two-step process: First, the enzyme searches for small matching sequences called “microhomologies” on broken strands. Once a matching sequence is found, Pol-theta holds the broken DNA strands together so that they can be stitched together—without needing extra energy. Most enzymes require an energy boost to function, but Pol-theta relies on the natural attraction between matching DNA sequences, allowing them to snap into place on their own. “If we can block this process, we could make Pol-theta-dependent cancers much more sensitive to treatment,” says Zerio. Importantly, Pol-theta is produced at low levels in healthy cells, making it a promising target for cancer therapies. Unlike cancer cells, which depend on Pol-theta as a workaround for defective repair pathways, healthy ones rely on more accurate repair mechanisms that require energy—ensuring more precise DNA repair. Because healthy cells don’t need Pol-theta for survival, blocking the enzyme’s activity likely won’t cause widespread damage to healthy tissue. “Most cancer drugs target proteins that are also needed by healthy cells,” notes Lander. “Specifically targeting Pol-theta should only kill cancer cells, lowering the chance of side effects during therapy.” Drugs that inhibit Pol-theta are already in clinical trials, but they currently must be combined with other therapies to work effectively. While this study could inform more precise drug development, further research may reveal other roles the enzyme may play in cellular functions. “We also want to understand why Pol-theta exists in its tetrameric form and how it interacts with other DNA repair enzymes,” says Lander. “Such insights could lead to new ways of targeting BRCA-associated cancers.” Reference: “Human polymerase θ helicase positions DNA microhomologies for double-strand break repair” by Christopher J. Zerio, Yonghong Bai, Brian A. Sosa-Alvarado, Timothy Guzi and Gabriel C. Lander, 28 February 2025, Nature Structural & Molecular Biology. DOI: 10.1038/s41594-025-01514-8 This work was supported by funding from the National Institutes of Health (F32CA288144, GM14305, and S10OD032467).

Scientists have developed a breakthrough microscopy technique to observe ribosomes in action as they translate mRNA into proteins. This method revealed that ribosomes cooperate when encountering obstacles, rather than just being removed by the cell’s quality control system. A new imaging technique reveals ribosomes work together when translating mRNA, preventing slowdowns in protein production. This discovery challenges prior beliefs and could revolutionize our understanding of cellular biology. Scientists from the Tanenbaum group at the Hubrecht Institute have developed an advanced microscopy technique to observe ribosomes in action inside living cells. This method allows researchers to track individual ribosomes as they translate mRNA into proteins. Their study uncovered a surprising phenomenon: ribosomes assist each other when they encounter obstacles, a process they call ‘ribosome cooperativity’. These findings, published today (January 31) in the journal Cell, provide new insights into protein synthesis and offer scientists a powerful tool to study mRNA translation more closely. DNA carries the genetic instructions needed for our bodies to function. Before these instructions can be used, they are copied into mRNA (messenger RNA), which acts as a blueprint. Ribosomes read this blueprint and build proteins — molecules essential for countless biological processes. The conversion of genetic information into proteins is called mRNA translation, a critical step in gene expression. Watching Ribosomes in Action “Sometimes, the mRNA contains sections that are challenging to translate into protein. We still don’t fully understand how ribosomes manage these sections,” says Maximilian Madern, one of the study’s lead authors. “That’s why we wanted to engineer a new imaging technology to gain a better understanding of how ribosomes carry out their jobs.” This new technique enables researchers to monitor an individual ribosome over time during mRNA translation. Using their technique, the team already gained new insights into how ribosomes function. “We observed that individual ribosomes move at slightly different speeds and sometimes pause for extended periods,” explains Sora Yang, the study’s second lead author. Due to their differences in speed ribosomes might collide, slowing down protein production. “Detecting these speed differences was challenging,” Yang continues. “So, we teamed up with Marianne Bauer’s group of computational scientists at TU Delft’s Department of Bionanoscience. With their expertise, we could demonstrate that ribosomes indeed operate at different speeds.” These spots are socRNAs being translated by ribosomes in a cell. They get brighter over time, showing active translation. The complex, which includes the socRNA and ribosome, is attached to the plasma membrane and moves slightly in 2D. Credit: Maximilian Madern, copyright Hubrecht Instituut Ribosomes Getting Stuck The team also made an important discovery about ribosome collisions—where one ribosome runs into another due to a tricky RNA segment or differences in speed for example. “We found that brief collisions do not immediately trigger the cell’s quality control mechanisms,” states Madern. “Normally, these mechanisms would remove collided ribosomes, but they kick in only if the collision lasts several minutes.” Collisions Not So Bad After All To their surprise, the researchers found that these temporary collisions could be beneficial, contrary to previous beliefs. Ribosomes appear to ‘help’ each other in navigating difficult-to-translate RNA sections, a phenomenon they call ‘ribosome cooperativity’. “This allows ribosomes to endure short collisions on problematic RNA sections, thereby promoting continuous protein production,” Madern explains. Expanding Possibilities for Future Research The new technology gives researchers the ability to better understand ribosome behavior on an individual level. By unraveling the dynamics of mRNA translation, researchers can gain deeper insights into cellular processes and the role of protein synthesis in health and disease. Reference: “Long-term imaging of individual ribosomes reveals ribosome cooperativity in mRNA translation” by Maximilian F. Madern, Sora Yang, Olivier Witteveen, Hendrika A. Segeren, Marianne Bauer and Marvin E. Tanenbaum, 31 January 2025, Cell. DOI: 10.1016/j.cell.2025.01.016 Marvin Tanenbaum is group leader at the Hubrecht Institute, professor of Gene Expression Dynamics at TU Delft, and Investigator at Oncode Institute.

DVDV1551RTWW78V